Category:
FUNDING
Medical device and diagnostics companies are always looking for ways to improve their products and services. In the ever-changing landscape of the healthcare industry, it’s essential for these companies to stay ahead of the curve. That’s why funding is always news.
Series A, B, and other rounds of funding are essential for medical device and diagnostics companies. They provide the necessary capital to help these businesses grow and innovate. And with so many investors interested in this space, there are plenty of opportunities for companies to secure the funding they need.
Vertex Ventures HC Announces $200 Million Fund III to Drive Innovation in Healthcare
Since its founding in 2014, Vertex Ventures HC $550M assets under management and invested in more than 25 portfolio companies to bring transformative therapies and healthcare technologies to patients, including nearly 20 clinical-stage assets and three products cleared by the US Food and Drug Administration
Tagworks Pharmaceuticals Announces $65 Million in Series A Financing to Advance Click-to-Release Therapeutics
The financing will support the advancement of TGW101, Tagworks' lead click-cleavable ADC program, and the company's proprietary Click-to-Release platform.
Conformal Medical Raises $35 Million in Oversubscribed Series D Round
The highly supported round reflects the progress and achievements made since its last funding round, which includes the initiation of the CONFORM Clinical Trial. The CONFORM Trial is the company's pivotal trial evaluating the safety and efficacy of the CLAAS® System compared to other commercially available LAAO devices and will support U.S. Food and Drug Administration (FDA) pre-market approval.
PathMaker Neurosystems Receives $200,000 START Award from MassVentures
“We are grateful for the Stage 2 award from MassVentures as we work to bring MyoRegulator® to market,” said Nader Yaghoubi, M.D., Ph.D., Co-Founder and Chief Executive Officer of PathMaker. “As we continue our US multi-center pivotal trial in post-stroke spasticity and work to launch our first clinical trial in ALS this year, MassVentures support for late-stage development of our product is greatly appreciated.”
Orthonika Awarded £1.34 Million Innovate UK Grant
“There is currently no widely available treatment solution that allows patients to return to a pain-free active lifestyle following meniscectomy,” said Maria Kristina Bartolo, Ph.D., Chief Technology Officer at Orthonika. “We are delighted that Innovate UK has recognised the potential for our novel total meniscus replacement to fulfill a significant unmet clinical need and further promote joint preservation.”
Dr Peter Staats, Chief Medical Officer at National Spine and Pain, Joins the Neuralace Medical Advisory Board
Dr Peter Staats brings extensive expertise to the company and will collaborate with the advisory board and Neuralace Medical to contribute valuable insights and strategic guidance.
Manus Neurodynamica Secures £2.6m
The funding will allow Manus Neurodynamica to continue its launch into the EU pharmacy retail sector, focused on prevention screening, and global clinical markets, helping to differentiate between Parkinson’s and other movement disorders, aiding the patient pathway and reducing costs.
RedDress Raises $26 Million to Give Patients the Power to Heal Chronic Wounds Using Their Own Blood
“Healing is in our blood, and we are grateful for the continued support from our investors as we advance our mission of supplying healthcare providers with an effective solution to treat chronic and complex wounds through an innovative system that harnesses the power of patient’s own blood,” said Alon Kushnir, CEO and co-founder at RedDress.
Artelon, Inc. Secures $20M in Funding to Advance Surgical Treatment of Joint Instability
The financing will fund the commercial growth of Artelon, clinical research, and expansion of Artelon’s product line for surgical treatment of ankles and other joints.
Medical Device News Magazine
